Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesNov 16, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 5, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 2, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 1, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesOct 26, 2018View HTMLDownload DOCDownload PDF
10-QQuarterly report which provides a continuing view of a company's financial positionOct 26, 2018View HTMLDownload DOCDownload PDFDownload XLSView XBRLDownload XBRL
8-KReport of unscheduled material events or corporate eventOct 25, 2018View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventOct 23, 2018View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesOct 5, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesOct 5, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 28, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 27, 2018View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventSep 24, 2018View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesSep 18, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 17, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 17, 2018View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesSep 7, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 6, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 30, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 29, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 28, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 22, 2018View HTMLDownload DOCDownload PDF
S-8 POSPost-effective amendment to an S-8 filingAug 22, 2018View HTMLDownload DOCDownload PDFDownload XLS
S-8 POSPost-effective amendment to an S-8 filingAug 22, 2018View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesAug 9, 2018View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-100      101-125      126-146

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information